Timing of maternal isoniazid preventive therapy on tuberculosis infection among infants exposed to HIV in low-income and middle-income settings: a secondary analysis of the TB APPRISE trial.

[1]  G. Montepiedra,et al.  Coordination of inflammatory responses in children with perinatally acquired HIV infection , 2022, AIDS.

[2]  M. Hughes,et al.  High Prevalence of Tuberculosis Infection and Disease in Child Household Contacts of Adults With Rifampin-resistant Tuberculosis , 2022, The Pediatric infectious disease journal.

[3]  T. Sterling,et al.  Lessons Learned from Implementation of an Interferon Gamma Release Assay to Screen for Latent Tuberculosis Infection in a Large Multicenter Observational Cohort Study in Brazil , 2021, Microbiology spectrum.

[4]  R. Chaisson,et al.  Tuberculosis screening among ambulatory people living with HIV: a systematic review and individual participant data meta-analysis , 2021, The Lancet. Infectious diseases.

[5]  Brian G. Williams,et al.  Isoniazid preventive therapy plus antiretroviral therapy for the prevention of tuberculosis: a systematic review and meta-analysis of individual participant data. , 2021, The lancet. HIV.

[6]  G. Montepiedra,et al.  Effects of Pregnancy and Isoniazid Preventive Therapy on M. tuberculosis Interferon Gamma Response Assays in Women with HIV. , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[7]  B. Richardson,et al.  A randomized controlled trial of isoniazid to prevent Mycobacterium tuberculosis infection in Kenyan HIV-exposed uninfected infants. , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[8]  Kaylynn Aiona,et al.  Interferon-Gamma Release Assay Testing in Children Younger Than 2 Years in a US-Based Health System , 2020, The Pediatric infectious disease journal.

[9]  H. Zar,et al.  The risk of tuberculosis in children after close exposure: a systematic review and individual-participant meta-analysis , 2020, The Lancet.

[10]  L. Myer,et al.  Safety and Effectiveness of Isoniazid Preventive Therapy in HIV-Positive Pregnant Women on Art: An Observational Study using Linked Population Data. , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[11]  A. Harries,et al.  Isoniazid preventive therapy: Uptake, incidence of tuberculosis and survival among people living with HIV in Bulawayo, Zimbabwe , 2019, PloS one.

[12]  G. Montepiedra,et al.  Isoniazid Preventive Therapy in HIV-Infected Pregnant and Postpartum Women. , 2019, The New England journal of medicine.

[13]  Degefaye Zelalem Anlay,et al.  Incidence and predictors of tuberculosis occurrence among adults on antiretroviral therapy at Debre Markos referral hospital, Northwest Ethiopia: retrospective follow-up study , 2019, BMC Infectious Diseases.

[14]  R. Chaisson,et al.  Building a tuberculosis-free world: The Lancet Commission on tuberculosis , 2019, The Lancet.

[15]  M. Hatherill,et al.  Diagnostic Accuracy of Early Secretory Antigenic Target-6–Free Interferon-gamma Release Assay Compared to QuantiFERON-TB Gold In-tube , 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[16]  G. Alter,et al.  Sex differences in vaccine-induced humoral immunity , 2018, Seminars in Immunopathology.

[17]  A. Mandalakas,et al.  High Incidence of Tuberculosis Infection in HIV-exposed Children Exiting an Isoniazid Preventive Therapy Trial , 2018, The Pediatric infectious disease journal.

[18]  H. Zar,et al.  Tuberculin skin test conversion and primary progressive tuberculosis disease in the first 5 years of life: a birth cohort study from Cape Town, South Africa , 2018, The Lancet. Child & adolescent health.

[19]  Helen E Jenkins,et al.  The global burden of tuberculosis mortality in children: a mathematical modelling study , 2017, The Lancet. Global health.

[20]  J. Andrews,et al.  Serial QuantiFERON testing and tuberculosis disease risk among young children: an observational cohort study. , 2017, The Lancet. Respiratory medicine.

[21]  B. Kampmann,et al.  The impact of BCG vaccination on tuberculin skin test responses in children is age dependent: evidence to be considered when screening children for tuberculosis infection , 2016, Thorax.

[22]  D. Havlir,et al.  Tuberculosis Infection in Early Childhood and the Association with HIV-exposure in HIV-uninfected Children in Rural Uganda , 2016, The Pediatric infectious disease journal.

[23]  Marco Schito,et al.  Clinical Case Definitions for Classification of Intrathoracic Tuberculosis in Children: An Update. , 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[24]  E. Chiappini,et al.  Interferon-Gamma Release Assay Sensitivity in Children Younger Than 5 Years is Insufficient to Replace the Use of Tuberculin Skin Test in Western Countries , 2014, The Pediatric infectious disease journal.

[25]  A. Benedetti,et al.  Reproducibility of interferon gamma (IFN-γ) release Assays. A systematic review. , 2014, Annals of the American Thoracic Society.

[26]  S. Esposito,et al.  Performance of interferon-&ggr; Release Assay for the Diagnosis of Active or Latent Tuberculosis in Children in the First 2 Years of Age: A Multicenter Study of the Italian Society of Pediatric Infectious Diseases , 2014, The Pediatric infectious disease journal.

[27]  G. Maartens,et al.  Isoniazid plus antiretroviral therapy to prevent tuberculosis: a randomised double-blind, placebo-controlled trial , 2014, The Lancet.

[28]  D. Shingadia,et al.  Epidemiology and disease burden of tuberculosis in children: a global perspective , 2014, Infection and drug resistance.

[29]  G. John-Stewart,et al.  High Prevalence of Tuberculosis Infection in HIV-1 Exposed Kenyan Infants , 2014, The Pediatric infectious disease journal.

[30]  M. Pai,et al.  Gamma Interferon Release Assays for Detection of Mycobacterium tuberculosis Infection , 2014, Clinical Microbiology Reviews.

[31]  B. Marais,et al.  Tuberculosis in children. , 2012, The New England journal of medicine.

[32]  Amita Gupta,et al.  Tuberculosis in pregnant and postpartum women: epidemiology, management, and research gaps. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[33]  C. Wiysonge,et al.  The Utility of an Interferon Gamma Release Assay for Diagnosis of Latent Tuberculosis Infection and Disease in Children: A Systematic Review and Meta-analysis , 2011, The Pediatric infectious disease journal.

[34]  P. Aaby,et al.  Impact of tuberculosis exposure at home on mortality in children under 5 years of age in Guinea-Bissau , 2010, Thorax.

[35]  K. Castro,et al.  Updated guidelines for using Interferon Gamma Release Assays to detect Mycobacterium tuberculosis infection - United States, 2010. , 2010, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.